By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Qiagen will provide molecular diagnostics screening to women in Rwanda as part of a national cervical cancer prevention effort announced today.

As part of the initiative announced by Merck, Qiagen, and the government of Rwanda, Qiagen will provide screening for women between the ages of 35 and 45, and Merck will vaccinate girls between 12 and 15 years of age during the first three years of the program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene regulation changes linked to human brain evolution, and more.

The New York Stem Cell Foundation's Initiative on Women in Science and Engineering working group presents seven strategies to promote gender equality in the sciences.

Researchers link a genetic variation to the ability to quickly process arsenic in people living in the Andes Mountains.

A small portion of pregnant women who've undergone non-invasive prenatal testing have found out from the test that they have cancer.